Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation (Q45374927)

13 December 2017

Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation (English)

1 reference

13 December 2017

0 references

1 reference

1 reference

Yoon-Jae Song

1

1 reference

PubMed ID

20585848

13 December 2017

Myung-Soo Kang

series ordinal

2

1 reference

13 December 2017

29 June 2010

1 reference

13 December 2017

1 reference

13 December 2017

41

1 reference

13 December 2017

2

1 reference

13 December 2017

174-180

1 reference

https://scigraph.springernature.com/pub.10.1007/s11262-010-0505-4

13 December 2017

0 references

cites work

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11262-010-0505-4

Regulation of NF-kappa B2 p100 processing by its cis-acting domain

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11262-010-0505-4

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

21 January 2018

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.

1 reference

12 December 2020

TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.

1 reference

12 December 2020

Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.

1 reference

12 December 2020

Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2

1 reference

12 December 2020

The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.

1 reference

12 December 2020

TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor

1 reference

12 December 2020

Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling

1 reference

12 December 2020

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression

1 reference

12 December 2020

The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

1 reference

12 December 2020

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

1 reference

12 December 2020

Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation

1 reference

12 December 2020

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

1 reference

12 December 2020

Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.

1 reference

12 December 2020

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

1 reference

12 December 2020

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

1 reference

12 December 2020

The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation

1 reference

12 December 2020

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

12 December 2020

CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.

1 reference

12 December 2020

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

1 reference

12 December 2020

Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines

1 reference

12 December 2020

Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation

1 reference

12 December 2020

Rescue of TRAF3-null mice by p100 NF-kappa B deficiency

1 reference

12 December 2020

Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway

1 reference

12 December 2020

Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway

1 reference

12 December 2020

NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

1 reference

12 December 2020

Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs

1 reference

12 December 2020

An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation

1 reference

12 December 2020

NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells

1 reference

12 December 2020

The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

1 reference

12 December 2020

Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus

1 reference

12 December 2020

Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes

1 reference

12 December 2020

Missing pieces in the NF-kappaB puzzle

1 reference

12 December 2020

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

1 reference

12 December 2020

Signaling to NF-kappaB

1 reference

12 December 2020

A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions

1 reference

12 December 2020

Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.

1 reference

12 December 2020

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells

1 reference

12 December 2020

10.1007/S11262-010-0505-4

Identifiers

DOI

1 reference

PubMed ID

20585848

Dimensions Publication ID

13 December 2017

0 references

1 reference

PubMed ID

20585848